The Turku Site, with 550 employees, represents one of PerkinElmer’s major manufacturing and product development sites for newborn-, maternal fetal health-, and prenatal screening. As the global market leader in newborn screening, our solutions have tested over 560 million babies worldwide for life-threatening diseases.
What we offer:
For more information please contact SW Engineering Manager Antti Iivonen by e-mail email@example.com.
If you are interested in the position and feel that you have the necessary skills and experience, please send your application and CV by 20th May 2018 via the link below. Please note that the position will be filled as soon as a suitable candidate is found.
PerkinElmer Turku Site is a drug free site and a medical examination for new employees includes a drug test.